These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 29443390)

  • 1. Tolerance limits and methodologies for IMRT measurement-based verification QA: Recommendations of AAPM Task Group No. 218.
    Miften M; Olch A; Mihailidis D; Moran J; Pawlicki T; Molineu A; Li H; Wijesooriya K; Shi J; Xia P; Papanikolaou N; Low DA
    Med Phys; 2018 Apr; 45(4):e53-e83. PubMed ID: 29443390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis of tolerance levels in IMRT quality assurance procedures.
    Basran PS; Woo MK
    Med Phys; 2008 Jun; 35(6):2300-7. PubMed ID: 18649462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IMRT QA: Selecting gamma criteria based on error detection sensitivity.
    Steers JM; Fraass BA
    Med Phys; 2016 Apr; 43(4):1982. PubMed ID: 27036593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breaking bad IMRT QA practice.
    Stojadinovic S; Ouyang L; Gu X; Pompoš A; Bao Q; Solberg TD
    J Appl Clin Med Phys; 2015 May; 16(3):5242. PubMed ID: 26103484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preliminary study on monitoring patient-specific volumetric modulated arc therapy quality assurance process with statistical process control methodology on the basis of TG-218 report].
    Xiao Q; Li G; Li Z; Zhang X; Dai G; Bai S
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2020 Oct; 37(5):842-847. PubMed ID: 33140608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TU-F-BRCD-01: Tolerance Levels and Methodologies for IMRT Verification QA.
    Miften M; Olch A; Low D
    Med Phys; 2012 Jun; 39(6Part24):3917. PubMed ID: 28518711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National survey of patient specific IMRT quality assurance in China.
    Pan Y; Yang R; Zhang S; Li J; Dai J; Wang J; Cai J
    Radiat Oncol; 2019 Apr; 14(1):69. PubMed ID: 31023348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tomotherapy treatment plan quality assurance: the impact of applied criteria on passing rate in gamma index method.
    Bresciani S; Di Dia A; Maggio A; Cutaia C; Miranti A; Infusino E; Stasi M
    Med Phys; 2013 Dec; 40(12):121711. PubMed ID: 24320497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A hybrid method to improve efficiency of patient specific SRS and SBRT QA using 3D secondary dose verification.
    Baltz GC; Manigold R; Seier R; Kirsner SM
    J Appl Clin Med Phys; 2023 Mar; 24(3):e13858. PubMed ID: 36583305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A method to reconstruct and apply 3D primary fluence for treatment delivery verification.
    Liu S; Mazur TR; Li H; Curcuru A; Green OL; Sun B; Mutic S; Yang D
    J Appl Clin Med Phys; 2017 Jan; 18(1):128-138. PubMed ID: 28291913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the accuracy of 3DVH software estimates of dose to virtual ion chamber and film in composite IMRT QA.
    Olch AJ
    Med Phys; 2012 Jan; 39(1):81-6. PubMed ID: 22225277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward optimizing patient-specific IMRT QA techniques in the accurate detection of dosimetrically acceptable and unacceptable patient plans.
    McKenzie EM; Balter PA; Stingo FC; Jones J; Followill DS; Kry SF
    Med Phys; 2014 Dec; 41(12):121702. PubMed ID: 25471949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survey results of 3D-CRT and IMRT quality assurance practice.
    Mehrens H; Taylor P; Followill DS; Kry SF
    J Appl Clin Med Phys; 2020 Jul; 21(7):70-76. PubMed ID: 32351006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvements in treatment planning calculations motivated by tightening IMRT QA tolerances.
    Stambaugh C; Gagneur J; Uejo A; Clouser E; Ezzell G
    J Appl Clin Med Phys; 2019 Jan; 20(1):250-257. PubMed ID: 30599085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the use of computed radiography plates for quality assurance of intensity modulated radiation therapy dose distributions.
    Day RA; Sankar AP; Nailon WH; MacLeod AS
    Med Phys; 2011 Feb; 38(2):632-45. PubMed ID: 21452701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and initial experience on patient specific quality assurance for clinical implementation of dynamic IMRT.
    Krishnamurthy K; Sivakumar SS; Davis CA; Ravichandran R; El Ghamrawy K
    Gulf J Oncolog; 2009 Jan; (5):44-8. PubMed ID: 20084785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical approach for pretreatment verification of IMRT with flattening filter free(FFF) beams using Varian Portal Dosimetry.
    Min S; Choi YE; Kwak J; Cho B
    J Appl Clin Med Phys; 2014 Jan; 16(1):4934. PubMed ID: 25679149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial clinical experience with ArcCHECK for IMRT/VMAT QA.
    Aristophanous M; Suh Y; Chi PC; Whittlesey LJ; LaNeave S; Martel MK
    J Appl Clin Med Phys; 2016 Sep; 17(5):20-33. PubMed ID: 27685107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient and reliable 3D dose quality assurance for IMRT by combining independent dose calculations with measurements.
    Visser R; Wauben DJ; de Groot M; Godart J; Langendijk JA; van't Veld AA; Korevaar EW
    Med Phys; 2013 Feb; 40(2):021710. PubMed ID: 23387733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving intensity-modulated radiation therapy quality assurance by adopting statistical process control.
    Cui T; Peng JX; Jin XL; Chu XG; Zhang J; Cui LZ; Xing XF
    Cancer Radiother; 2022 May; 26(3):427-432. PubMed ID: 34090790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.